Sign up to save your podcasts
Or
Share Multiple Sclerosis, Rituximab, Hypogammaglobulinemia and Risk of Infections
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
Multiple Sclerosis, Rituximab, Hypogammaglobulinemia and Risk of Infections
Dr. Shuvro Roy and Dr. Annette Langer-Gould discuss the effective dose of rituximab and other B-cell depleting therapies in patients with multiple sclerosis, as well as important comorbidities to prevent infection risks.
Show reference:
https://www.neurology.org/doi/10.1212/NXI.0000000000200211
View all episodes
By American Academy of Neurology
4.8
129129 ratings
Dr. Shuvro Roy and Dr. Annette Langer-Gould discuss the effective dose of rituximab and other B-cell depleting therapies in patients with multiple sclerosis, as well as important comorbidities to prevent infection risks.
Show reference:
https://www.neurology.org/doi/10.1212/NXI.0000000000200211
More shows like Neurology Minute
View all
JAMA Clinical Reviews
496 Listeners
Neurology® Podcast
300 Listeners
Practical Neurology Podcast
48 Listeners
Mayo Clinic Talks
291 Listeners
The Curbsiders Internal Medicine Podcast
3,331 Listeners
Emergency Medical Minute
263 Listeners
JAMA Neurology Author Interviews
12 Listeners
Neurology Today in 5
22 Listeners
Annals On Call Podcast
195 Listeners
The Clinical Problem Solvers
514 Listeners
Harrison's PodClass: Internal Medicine Cases and Board Prep
365 Listeners
Short Wave
6,415 Listeners
Neurology Exam Prep Podcast
179 Listeners
The Curious Clinicians
369 Listeners
Continuum Audio
79 Listeners